Munafa Stock Market Course + Intraday & FNO calls 
Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Audentes Therapeutics (BOLD)
Technical Analysis Report for USA stock BOLD Audentes Therapeutics. Dated: 30 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock BOLD Audentes Therapeutics then click here. or read Experts views on Audentes Therapeutics or Forecast & share price targets of Audentes Therapeutics
Audentes Therapeutics Opened at 1.16 and Closed at: 1.16, which is -1.72% of previous session's close. It moved within a range of 1.13 and 1.17
The session was a Neutral session with an average volume of 122300, which is 56.58% of previous session's volumes.
A Dead cross was found 2 days back on short term averages
Support for tomorrow is 1.14 and resistance for tomorrow is 1.18
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.14, 1.11 resistance for tomorrow's hourly charts is 1.18, 1.19
10 Day SMA for Audentes Therapeutics (BOLD) is 1.22 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Audentes Therapeutics (BOLD) is 1.24 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Audentes Therapeutics (BOLD) is 1.19 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1.23 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Audentes Therapeutics is 1.24 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Audentes Therapeutics is at 1.24 and 200 DMA is at 1.24, while 50 DMA and 100 DMA are at 1.19 and 1.23 respectively
Audentes Therapeutics (BOLD) moving average of 20 SMA is at 1.24 and 20 EMA is at 1.21
| Date | Closing Price | 20 SMA | 20 EMA |
| 30 Fri Jan | 1.16 | 1.24 | 1.21 |
| 29 Thu Jan | 1.18 | 1.24 | 1.22 |
| 28 Wed Jan | 1.21 | 1.24 | 1.22 |
| 27 Tue Jan | 1.22 | 1.24 | 1.22 |
| 26 Mon Jan | 1.23 | 1.24 | 1.22 |
| 23 Fri Jan | 1.26 | 1.24 | 1.22 |
Audentes Therapeutics (BOLD) moving average of 50 SMA is at 1.19 and 50 EMA is at 1.22
| Date | Closing Price | 50 SMA | 50 EMA |
| 30 Fri Jan | 1.16 | 1.19 | 1.22 |
| 29 Thu Jan | 1.18 | 1.19 | 1.22 |
| 28 Wed Jan | 1.21 | 1.19 | 1.22 |
| 27 Tue Jan | 1.22 | 1.19 | 1.22 |
| 26 Mon Jan | 1.23 | 1.19 | 1.22 |
| 23 Fri Jan | 1.26 | 1.19 | 1.22 |
Audentes Therapeutics (BOLD) moving average of 100 SMA is at 1.23 and 100 EMA is at 1.33
| Date | Closing Price | 100 SMA | 100 EMA |
| 30 Fri Jan | 1.16 | 1.23 | 1.33 |
| 29 Thu Jan | 1.18 | 1.23 | 1.33 |
| 28 Wed Jan | 1.21 | 1.23 | 1.33 |
| 27 Tue Jan | 1.22 | 1.23 | 1.33 |
| 26 Mon Jan | 1.23 | 1.23 | 1.33 |
| 23 Fri Jan | 1.26 | 1.23 | 1.33 |
Audentes Therapeutics (BOLD) moving average of 200 SMA is at 1.24 and 200 EMA is at 1.59
| Date | Closing Price | 200 SMA | 200 EMA |
| 30 Fri Jan | 1.16 | 1.24 | 1.59 |
| 29 Thu Jan | 1.18 | 1.24 | 1.59 |
| 28 Wed Jan | 1.21 | 1.24 | 1.59 |
| 27 Tue Jan | 1.22 | 1.24 | 1.59 |
| 26 Mon Jan | 1.23 | 1.24 | 1.59 |
| 23 Fri Jan | 1.26 | 1.24 | 1.59 |
Audentes Therapeutics has performed better than Teleflex Incorporated in short term. Holding Audentes Therapeutics could be a better choice for now!
Edwards Lifesciences has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Edwards Lifesciences, about 0.27% more returns!
Theravance Biopharma has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Theravance Biopharma, about 9.27% more returns!
Sarepta Therapeutics has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Sarepta Therapeutics, about 0.37% more returns!
Syndax Pharmaceuticals has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Syndax Pharmaceuticals, about 0.32% more returns!
Audentes Therapeutics has performed better than Sellas Life in short term. Holding Audentes Therapeutics could be a better choice for now!
Rockwell Medical has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Rockwell Medical, about 29.34% more returns!
Audentes Therapeutics has performed better than Phio Pharmaceuticals in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Mustang Bio in short term. Holding Audentes Therapeutics could be a better choice for now!
Kiniksa Pharmaceuticals has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Kiniksa Pharmaceuticals, about 9.47% more returns!
Immuron has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Immuron, about 21.17% more returns!
Establishment Labs has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Establishment Labs, about 3.92% more returns!
Dynavax Technologies has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Dynavax Technologies, about 5.57% more returns!
Audentes Therapeutics has performed better than Citius Pharmaceuticals in short term. Holding Audentes Therapeutics could be a better choice for now!
Celcuity Inc has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Celcuity Inc, about 13.74% more returns!
Biomarin Pharmaceutical has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Biomarin Pharmaceutical, about 0.03% more returns!
Audentes Therapeutics has performed better than Biomerica Inc in short term. Holding Audentes Therapeutics could be a better choice for now!
Array Biopharma has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Array Biopharma, about 21.86% more returns!
Aclaris Therapeutics has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Aclaris Therapeutics, about 26.8% more returns!
Audentes Therapeutics Technical analysis of indicators
Price action analysis of Audentes Therapeutics (BOLD) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Audentes Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Audentes Therapeutics in short term but the sell signal is initial and weak.
Audentes Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Audentes Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Audentes Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.23 and Audentes Therapeutics BOLD stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Audentes Therapeutics BOLD stock. Volume based technical analysis of Audentes Therapeutics BOLD stock is negative.
Audentes Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock BOLD Audentes Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And BOLD Experts View which covers a lot of information including buying and selling signals
BOLD future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Audentes Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
